Evolution of the Average Target: Iqvia Holdings Inc.

Evolution of the Target Price: Iqvia Holdings Inc.

Changes in Analyst Recommendations: Iqvia Holdings Inc.

4f.IeM-Q580u9tspNMIkEg0ywKmyysYDH3csREL447vzmw.cJRGLvF99u4r6J5k8gV4_njXoGZBbRCJxktgk_6ZgBl7t1gN5X33vyHnhg~e24dd89672fc6a322968979e51881b33
03-09 IQVIA Shares Rise After TD Cowen Upgrade MT
03-09 Baird Adjusts Price Target on IQVIA Holdings to $243 From $268 MT
03-09 TD Cowen Upgrades IQVIA Holdings to Buy From Hold, Raises Price Target to $213 From $174 MT
03-09 Analyst recommendations: Dow, Jefferies, Paramount, Snap, Oracle… Zonebourse
03-06 Argus Research Adjusts IQVIA Holdings PT to $215 From $230, Maintains Buy Rating MT
03-06 Barclays Upgrades IQVIA Holdings to Overweight From Equal Weight, $210 Price Target MT
03-03 IQVIA Seen Benefiting From Clinical Trial Rebound Through 2026 on AI Strength, RBC Says MT
02-24 HSBC Adjusts Price Target on IQVIA Holdings to $240 From $270, Maintains Buy Rating MT
02-20 Mizuho Adjusts Price Target on IQVIA to $215 From $266, Maintains Outperform Rating MT
02-20 Analyst recommendations: Walmart, Alphabet, Deere & Company, Stellantis, Workday… Zonebourse
02-19 Truist Securities Cuts IQVIA Price Target to $245 From $290, Maintains Buy Rating MT
02-17 TD Cowen Adjusts Price Target on IQVIA to $174 From $245, Maintains Hold Rating MT
02-17 Analyst recommendations: Accenture, Dollar Tree, DraftKings, Moderna, Walmart… Zonebourse
02-06 UBS Adjusts Price Target on IQVIA to $240 From $280, Maintains Buy Rating MT
02-06 Leerink Partners Adjusts Price Target on IQVIA Holdings to $228 From $256, Maintains Outperform Rating MT
02-06 Evercore ISI Adjusts Price Target on IQVIA Holdings to $225 From $250, Maintains Outperform Rating MT
02-06 BMO Capital Adjusts Price Target on IQVIA Holdings to $250 From $260, Maintains Outperform Rating MT
02-06 Barclays Adjusts IQVIA Price Target to $210 From $230, Maintains Equal Weight Rating MT
02-06 JPMorgan Adjusts IQVIA Price Target to $225 From $255, Maintains Overweight Rating MT
02-06 Citigroup Adjusts IQVIA Price Target to $200 From $230, Maintains Neutral Rating MT
02-06 Jefferies Adjusts Price Target on IQVIA Holdings to $255 From $270, Maintains Buy Rating MT
02-06 Stifel Adjusts Price Target on IQVIA Holdings to $220 From $273, Maintains Buy Rating MT
02-05 IQVIA backs AI strategy as analysts question impact on business RE
02-02 Obesity market sales potential tightens as Novo and Lilly enter new era RE
01-22 TD Cowen Adjusts Price Target on IQVIA Holdings to $245 From $215, Maintains Hold Rating MT

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+44.96%
+39.48%
+43.6%
+23.28%
+36.06%
+24.73%
+10.33%
+16.29%
+29.8%
Average +29.84%
Weighted average by Cap. +33.29%
See all sector consensus

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
25
Last Close Price
162.93USD
Average target price
236.19USD
Spread / Average Target
+44.96%
High Price Target
287.00USD
Spread / Highest target
+76.15%
Low Price Target
200.00USD
Spread / Lowest Target
+22.75%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

Baird
TD Cowen
Argus
Barclays
HSBC
Mizuho Securities
Truist Securities
UBS
Leerink Partners
Evercore ISI
BMO Capital
JPMorgan Chase
Citigroup
Jefferies & Co.
Stifel Nicolaus
Rothschild & Co Redburn
Deutsche Bank Securities
Morgan Stanley
Stephens Inc.
BofA Securities
Redburn Atlantic
Goldman Sachs
BTIG
Nephron Research
RBC Capital Markets
Guggenheim
Wells Fargo Securities
Cowen
Credit Suisse
SVB Securities LLC
Piper Sandler
KeyBanc Capital Markets
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
25
Last Close Price
162.93USD
Average target price
236.19USD
Spread / Average Target
+44.96%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. IQV Stock
  4. Consensus Iqvia Holdings Inc.
SPRING SALE - 40%: The Best Tools Reserved for Subscribers to Identify Tomorrow's Top Investments!
d
:
:
BENEFIT NOW